Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i>-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
The New England Journal of Medicine|June 2, 2025
Overall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast CancerKomal L Jhaveri, Seock-Ah Im, Cristina Saura, et al.
Current Atherosclerosis Reports|September 15, 2025
Tackling the Cardio-Kidney-Metabolic Burden in CancerTarek Nahle, Viraj Shah, Harikrishnan Hyma Kunhiraman, et al.
Breast Cancer Research and Treatment|July 2, 2021
Diffuse optical tomography breast imaging measurements are modifiable with pre-surgical targeted and endocrine therapies among women with early stage breast cancerJulia E McGuinness, Mirella L Altoe, Alessandro Marone, et al.
Science Advances|January 6, 2023
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicityZiyi Fu, Siqi Chen, Yueming Zhu, et al.
Clinical Breast Cancer|July 10, 2026
Refining Stratification in Premenopausal Node-Positive HR<sup>+</sup>/HER2<sup>-</sup> Breast Cancer With a Novel AI-Based TestJailan Elayoubi, Cerise Tang, Kathryn J Ruddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline UpdateN Lynn Henry, Mark R Somerfield, Zoneddy Dayao, et al.
Clinical Nuclear Medicine|December 5, 2022
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and AdnexaIsmaheel O Lawal, Omotayo Atinuke Adediran, Saima Muzahir, et al.
Clinical Nuclear Medicine|February 2, 2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response AssessmentOmotayo A Adediran, Ismaheel O Lawal, Saima Muzahir, et al.
Therapeutic Advances in Medical Oncology|April 30, 2024
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapyAditya Bardia, Lajos Pusztai, Kathy Albain, et al.
Pageof 16